Affiliation:
1. Lokmanya Tilak Medical and Municipal General Hospital, Mumbai, Maharashtra, India
2. L
Abstract
It becomes important to detect chromosomal abnormalities prenatally and early in the pregnancy. The present thesis is aimed to assess the performance of prenatal screening tests for chromosomal abnormalities detection i.e., dual marker test, first trimester ultrasound which measures the nuchal translucency and presence or absence of nasal bone, and their correlation with diagnostic test which is the karyotyping after amniocentesis. It is a prospective & observational clinical study conducted in Obstetrics and gynaecology department of a tertiary care hospital. Two hundred pregnant females above 18 years of age attending ANC OPD (Antenatal Check-up Out-patient department) were considered for this study. In this study we found the presence of chromosomal abnormalities in 10% of participants. Combined sensitivity of NT and Dual marker test was found to be 83.75% in detecting chromosomal abnormalities. It can be concluded at the end of the study that; prenatal diagnosis with ultrasonography for nuchal translucency either alone or in combination with dual marker test offered good detection rate for these chromosomal abnormalities.
Publisher
IP Innovative Publication Pvt Ltd
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference11 articles.
1. Rao L, Murthy K, Babu A, Venkata P, Deenadayal M, Singh L, Chromosome inversions and a novel chromosome insertion associated with recurrent miscarriages in South India.Arch Gynecol Obstet 2005;272(4):273-7
2. Cuckle HS, Wald NJ, Thompson SG, Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level.Br J Obstet Gynaecol 1987;94(5):387-402
3. Neagos D, Cretu R, Sfetea RC, Bohiltea LC, The importance of screening and prenatal diagnosis in the identification of the numerical chromosomal abnormalities. Maedica (Buchar).Maedica (Bucur) 2011;6(3):179-84
4. Comas C, Torrents M, Muñoz, A, Antolín E, Figueras F, Echevarría M, Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?.Obstet Gynecol 2002;100(4):648-54
5. Szabó J, Gelén J, Szemere G, First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age.Ultrasound Obstet Gynecol 1995;5(3):161-3